GlassScriptPhysician profile
Kapil Dua
NPI 1114176765
$1,621.79
in general payments reported to CMS, 2019-2025
26 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $37.01 · 2021: $133 · 2022: $488 · 2023: $208 · 2024: $150 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $214.08 | 2021-2022 | |
| Smith+Nephew, INC. | $179.21 | 2019-2024 | Grafix Pl |
| Paratek Pharmaceuticals, INC. | $166.63 | 2021-2025 | Nuzyra |
| Nevro Corp. | $146.31 | 2022-2024 | Senza |
| Melinta Therapeutics, LLC | $126.00 | 2019-2025 | Orbactiv, Kimyrsa |
| Abbvie INC. | $106.86 | 2021-2025 | Dalvance |
| Kowa Pharmaceuticals America, INC. | $81.72 | 2022-2023 | Seglentis |
| Aroa Biosurgery Incorporated | $80.55 | 2019-2024 | |
| Convatec INC. | $51.66 | 2023-2024 | |
| Stryker Corporation | $46.60 | 2021-2024 | Citrefix |
| Kerecis Limited | $43.19 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Horizon Therapeutics Plc | $42.99 | 2019 | |
| Globus Medical, INC. | $38.11 | 2025 | Senza |
| Integra Lifesciences Corporation | $38.10 | 2019 | |
| Bioventus LLC | $29.92 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $28.93 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $27.69 | 2019 | |
| Access Pro Medical, LLC | $25.64 | 2025 | Matriderm |
| Polynovo North America LLC | $25.26 | 2022 | |
| Tactile Systems Technology INC | $23.08 | 2023 | Flexitouch Plus, Entre Plus |
| Solventum Corporation | $21.26 | 2025 | Promogran Prisma, Activ.A.C. |
| Wright Medical Technology, INC. | $21.04 | 2020 | |
| Acumed LLC | $18.27 | 2025 | Acumed |
| Zimmer Biomet Holdings, INC. | $15.97 | 2020 | |
| Nabriva Therapeutics, Plc | $11.79 | 2021 | |
| Osiris Therapeutics INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kapil Dua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.